Markets:

Overview

News

Currencies

International

Treasuries

Reata Pharmaceuticals, Inc. - Class A Common Stock (NQ:RETA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 25, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Reata Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

3 Top Biotech Stocks Defying the Bear Market ↗

July 13, 2023

Each has the potential to dramatically outperform the market.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023 ↗

July 06, 2023

Via Benzinga

Stock Market Rally Roars Back Toward Highs; Carnival, Delta, Micron, Nvidia In Focus: Weekly Review ↗

June 30, 2023

Major indexes rebounded strongly and many stocks flashed buy signals.

Via Investor's Business Daily

What 5 Analyst Ratings Have To Say About Reata Pharmaceuticals ↗

June 28, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About Reata Pharmaceuticals ↗

June 12, 2023

Via Benzinga

Reata Surges 16% Over Three Days; CEO Reflects On The Tricky Path To Launch A First-Ever Drug ↗

June 29, 2023

The company can now launch its Friedreich's ataxia treatment, Skyclarys.

Via Investor's Business Daily

Reata Nears Breakout After Snagging FDA Blessing To Launch Its Friedreich's Ataxia Drug ↗

June 28, 2023

The company has now launched its treatment for Friedreich's ataxia, despite numerous obstacles.

Via Investor's Business Daily

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

June 28, 2023

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on!

Via InvestorPlace

Top 1% Biotech Stock Reata Pharmaceuticals Faces Another Hurdle ↗

June 16, 2023

Reata Pharmaceuticals took another step toward launching its highly anticipated drug, Skyclarys.

Via Investor's Business Daily

Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 15, 2023

Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 281% to $0.8396.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023 ↗

June 12, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 09, 2023

Via Benzinga

The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree ↗

June 02, 2023

Big Pharma is facing a patent cliff that could siphon off billions in revenue.

Via Investor's Business Daily

Reata Pharmaceuticals Stock Plummets More Than 20%: Here's Why ↗

May 10, 2023

Reata Pharmaceuticals Inc (NASDAQ: RETA) and its partner Kyowa Kirin Co Ltd have decided to discontinue

Via Benzinga

Reata Pharma Tumbles After Scrapping Its Kidney Drug As Earnings Come In Mixed ↗

May 10, 2023

Reata scrapped development of bardoxolone in chronic kidney disease.

Via Investor's Business Daily

How Biohaven Is Coming 'Out Of Stealth Mode' — And Bullishly Extending A 4-Day Run ↗

June 01, 2023

Shares surged into and out of the company's R&D Day, which included a surprise.

Via Investor's Business Daily

Abercrombie & Fitch, Urban Outfitters, Photronics And Other Big Stocks Moving Higher On Wednesday ↗

May 24, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 200 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 12, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 10, 2023

Via Benzinga

Recap: Reata Pharmaceuticals Q1 Earnings ↗

May 10, 2023

Via Benzinga

Earnings Outlook For Reata Pharmaceuticals ↗

May 09, 2023

Via Benzinga

Where Reata Pharmaceuticals Stands With Analysts ↗

April 13, 2023

Via Benzinga

Where Reata Pharmaceuticals Stands With Analysts ↗

March 27, 2023

Via Benzinga

Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 10, 2023

Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

May 10, 2023

It's time for another dive into the biggest pre-market stock movers as we see what shares are on rising and falling on Tuesday!

Via InvestorPlace

2 Top Healthcare Stocks Defying the Bear Market ↗

March 07, 2023

These two healthcare stocks have been swimming against the current.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 08, 2023

Via Benzinga

3 Stocks That Already Doubled in 2023 and Could Keep Climbing ↗

April 11, 2023

The gains these stocks notched in the first few months of the year could be the beginning of a much longer bull run.

Via The Motley Fool

The 3 Best Growth Stocks to Buy in the Biotech Sector ↗

March 29, 2023

These three biotech growth stocks are brimming with potential and could offer massive upside for patient investors.

Via InvestorPlace

3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing ↗

March 19, 2023

The high-flyers have soared to new heights and further gains could be up ahead.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Reata Pharmaceuticals, Inc. - Class A Common Stock (NQ:RETA)

Headline News about Reata Pharmaceuticals, Inc. - Class A Common Stock

Starting at $3.75/week.

Subscribe Today